Hydrocortisone and testosterone are just two of 13 drugs and supplements that could lessen the impact of genes that ...

Ahmedabad: Zydus Lifesciences Limited has received final approval from the United States Food and Drug Administration (USFDA) ...

Keros Therapeutics' stock has plummeted over 70% due to safety issues in its phase 2 PAH study, halting all trial arms. Learn more about KROS stock here.

Good day, and welcome to the Legend Biotech Fourth Quarter and Full-Year 2024 Earnings Call. At this time, all participants are in a listen-only mode. After the speakers' presentation, there will be a ...

Bristol-Myers Squibb’s Sprycel (dasatinib) and Novartis’ Tasigna (nilotinib), which made more than $1 billion in the first half of this year. If approved, asciminib would beef up Novartis ...

Zydus Lifesciences on Tuesday said it has entered into exclusive negotiations to acquire a majority stake in France-based Amplitude Surgical for 256.8 million euros (nearly $280 million). The company ...